Experts say the exact amount of risk isn't known, though it's very low
GLP-1 medications support appetite regulation and weight management
The FAAs Perspective on Diabetes Mellitus Diabetes Mellitus is not a single disease but a group of metabolic conditions characterized by elevated blood glucose (sugar) levels
This is the problem with it all along. The FDA has warned that its received reports of dosing errors with compounded semaglutide products, including some that resulted in hospitalization, and that some products sold by compounders used salt forms of semaglutide, which are different active ingredients than are used in the approved drugs. Its also warned about counterfeit versions of drugs and medicines sold that are falsely labeled for research purposes or not for human consumption, which the agency said could be harmful
While this is still being studied, it is a possible explanation for why some people feel emotionally different on semaglutide
Who Should Prioritize Storage Vigilance and Provider Communication Patients with baseline metabolic variationssuch as those with genetic predispositions affecting GLP-1 receptor sensitivity or peptide metabolismmay experience more noticeable shifts in efficacy if medication potency fluctuates due to storage issues
